In addition, a study conducted by Jeon H-Metal [42] suggested that an inhibitor of differentiation 4 (ID4) increases the SOX2-mediated expression of ABCC6 and ABCC3 in glioma stem cells (GSC), which have the potential to initiate a brain tumor, show resistance to chemotherapy, and are responsible for higher recurrence rates of Glioblastoma multiforme (GBM) [43]. The gene discussed is SOX2; the disease is glioblastoma.